,85 Notably, the AKT inhibitor MK2206 exercised a pronounced impact on SOX2 expression within all evaluated SOX2-positive esophageal squamous cell carcinoma cell lines, notably hampering tumor sphere formation.83 Here, AKT1 is linked to esophageal squamous cell carcinoma.